Allergology International

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

Authorship criteria: substantial contribution, writing/critical revision, approval of final version; contributions statement on title page. Model summary

All people listed as authors of the manuscript should have contributed substantially to study planning, data collection, or interpretation of results and have written or critically revised the manuscript and approved its final submitted version. Describe each individual's contribution to the work in a short statement of authors' contributions on the title page.Statement example: AB, CD, and EF des…

COI: ICMJE COI Disclosure form required; corresponding author compiles statement on title page. Model summary

Each author who is listed on the title page must declare any financial support or relationships that may pose a conflict of interest, using the ICMJE COI Disclosure form. The corresponding author is required: 1) to confirm whether all authors have filled out the form, 2) to write the COI statement covering all the authors' statements in the title page of the manuscript, 3) to submit to the journal…

Funding sources declared in Acknowledgements with role of sponsors. Model summary

Articles should declare sources of support for the work, including sponsor names along with explanations of the role of those sources, if any, in study design; collection, analysis, and interpretation of data; writing the report; or a statement declaring that the supporting source had no such involvement.

Ethics: human studies require ethics committee approval statement with approval number in Methods. Model summary

Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee (e.g., of the institution within which the work was undertaken).

License: CC BY-NC-ND. Model summary

Papers accepted for publication become copyrighted by the Japanese Society of Allergology, and all authors will be asked to sign a transfer of copyright form. In signing the transfer of copyright, it is assumed that authors have obtained permission to use any copyrighted or previously published material. All authors must read and agree to the conditions outlined in the Copyright Transfer Form and …

Double publication prohibited; must be stated in cover letter. Model summary

Every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format, immediately after publication. Authors do not incur any publication charges for open access: the Japanese Society of Allergology will pay to make the article open access.A CC user…

Peer review: single blind, minimum two independent expert reviewers; Editor may reject without peer review. Model summary

This journal uses a single blind review process. All contributions are sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the decision regarding acceptance or rejection of articles. The Editor's decision is final. The Editor may decide to reject manuscripts without sending them out for peer review. For more information…

Plagiarism screening via CrossCheck (iThenticate). Model summary

Submitted manuscripts will be checked by CrossCheck (powered by iThenticate), the plagiarism checker software.

Preprint policy: preprint-posted articles can be submitted; server name and URL required in cover letter. Model summary

Articles previously published on preprint servers can be submitted. Authors need to mention the name of preprint server and the URL in the cover letter.

Clinical trials must be registered in a public trials registry per ICMJE guidelines. Model summary

This journal follows the International Committee of Medical Journal Editors (ICMJE) clinical trials registration guidelines. Registration Clinical trials must be registered in a public trials registry.